E7-C13

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameE7-C13
Drug Alias NameE7-C13
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor-like protein 7 inhibitors
TargetsEpidermal growth factor-like protein 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alberta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Alberta
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A